Insights into the mechanisms of protective immunity against Cryptococcus neoformans infection using a mouse model of pulmonary cryptococcosis

PLoS ONE

Volumn 4, Issue 9, 2009, Pages

  Wozniak, Karen L ^a   Ravi, Sailatha ^a   Macias, Sandra ^a   Young, Mattie L ^a   Olszewski, Michal A ^b,c   Steele, Chad ^d   Wormley Jr , Floyd L ^a  

^a UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FUNGUS VACCINE; GAMMA INTERFERON; GLYCOPROTEIN P 15095; INTERLEUKIN 12P35; INTERLEUKIN 12P40; INTERLEUKIN 4 RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; FUNGUS ANTIBODY;

ACTIVE IMMUNIZATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4 LYMPHOCYTE COUNT; CELL INFILTRATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; CYTOKINE PRODUCTION; IMMUNIZATION; LEUKOCYTE; LUNG GRANULOMATOSIS; LUNG MYCOSIS; LYMPHOCYTE SUBPOPULATION; MOUSE; NONHUMAN; PASSIVE IMMUNIZATION; TH1 CELL; ANIMAL; BAGG ALBINO MOUSE; CRYPTOCOCCOSIS; CYTOLOGY; DISEASE MODEL; FEMALE; IMMUNOLOGY; LUNG; METABOLISM; MICROBIOLOGY; T LYMPHOCYTE;

FILOBASIDIELLA NEOFORMANS; MUS;

ANIMALS; ANTIBODIES, FUNGAL; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; IMMUNITY, CELLULAR; LEUKOCYTES; LUNG; LUNG DISEASES, FUNGAL; MICE; MICE, INBRED BALB C; T-LYMPHOCYTES; TH1 CELLS;

EID: 70149108073     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0006854     Document Type: Article

References (67)

1. Levitz SM (1991) The ecology of Cryptococcus neoformans and the epidemiology of cryptococcosis. Rev Infect Dis 13: 1163-1169.
2. Mitchell TG, Perfect JR (1995) Cryptococcosis in the Era of AIDS - 100 years after the discovery of Cryptococcus neoformans. Clin Microbiol Rev 8: 515-548.
3. Shoham S, Levitz SM (2005) The immune response to fungal infections. Br J Haematol 129: 569-582.
4. Singh N, Gayowski T, Wagener MM, Marino IR (1997) Clinical spectrum of invasive cryptococcosis in liver transplant recipients receiving tacrolimus. Clin Transplant 11: 66-70.
5. Singh N, Dromer F, Perfect JR, Lortholary O (2008) Cryptococcosis in solid organ transplant recipients: current state of the science. Clin Infect Dis 47: 1321-1327.
6. + T-Cells. J Exp Med 173: 755-758.
7. Huffnagle GB, Lipscomb MF, Lovchik JA, Hoag KA, Street NE (1994) The role of CD4(+) and CD8(+) T-Cells in the protective inflammatory response to a pulmonary cryptococcal infection. J Leukoc Biol 55: 35-42.
8. + T-Cells. J Exp Med 173: 793-800.
9. Huffnagle GB, Yates JL, Lipscomb MF (1991) T-cell-mediated immunity in the lung - a Cryptococcus neoformans pulmonary infection model using SCID and athymic nude-mice. Infect Immun 59: 1423-1433.
10. Mody CH, Lipscomb MF, Street NE, Toews GB (1990) Depletion of CD4+ (L3T4+) lymphocytes in vivo impairs murine host defense to Cryptococcus neoformans. J Immunol 144: 1472-1477.
11. Chuck SL, Sande MA (1989) Infections with Cryptococcus neoformans in the Acquired Immunodeficiency Syndrome. New Engl J Med 321: 794-799.
12. Blasi E, Mazzolla R, Barluzzi R, Mosci P, Bistoni F (1994) Anticryptococcal resistance in the mouse brain: beneficial effects of local administration of heat-inactivated yeast cells. Infect Immun 62: 3189-3196.
13. + T Lymphocytes in Host Resistance against Cryptococcus neoformans in the Central Nervous System of Immunized Mice. Infect Immun 68: 456-462.
14. Herring AC, Lee J, McDonald RA, Toews GB, Huffnagle GB (2002) Induction of interleukin-12 and gamma interferon requires tumor necrosis factor alpha for protective T1-cell-mediated immunity to pulmonary Cryptococcus neoformans infection. Infect Immun 70: 2959-2964.
15. Decken K, Kohler G, Palmer-Lehmann K, Wunderlin A, Mattner F, et al. (1998) Interleukin-12 Is Essential for a Protective Th1 Response in Mice Infected with Cryptococcus neoformans. Infect Immun 66: 4994-5000.
16. Kawakami K, Qifeng X, Tohyama M, Qureshi MH, Saito A (1996) Contribution of tumour necrosis factor-alpha (TNF-alpha) in host defence mechanism against Cryptococcus neoformans. Clin Exp Immunol 106: 468-474.
17. Kawakami K, Tohyama M, Teruya K, Kudeken N, Xie QF, et al. (1996) Contribution of interferon-gamma in protecting mice during pulmonary and disseminated infection with Cryptococcus neoformans. FEMS Immunol Med Microbiol 13: 123-130.
18. Kawakami K, Tohyama M, Xie Q, Saito A (1996) IL-12 protects mice against pulmonary and disseminated infection caused by Cryptococcus neoformans. Clin Exp Immunol 104: 208-214.
19. Zhou Q, Gault RA, Kozel TR, Murphy WJ (2007) Protection from Direct Cerebral Cryptococcus Infection by Interferon-{gamma}-Dependent Activation of Microglial Cells. J Immunol 178: 5753-5761.
20. Bauman SK, Huffnagle GB, Murphy JW (2003) Effects of tumor necrosis factor alpha on dendritic cell accumulation in lymph nodes draining the immunization site and the impact on the anticryptococcal cell-mediated immune response. Infect Immun 71: 68-74.
21. Huffnagle GB, Toews GB, Burdick MD, Boyd MB, McAllister KS, et al. (1996) Afferent phase production of TNF-alpha is required for the development of protective T cell immunity to Cryptococcus neoformans. J Immunol 157: 4529-4536.
22. Kawakami K, Tohyama M, Qifeng X, Saito A (1997) Expression of cytokines and inducible nitric oxide synthase mRNA in the lungs of mice infected with Cryptococcus neoformans: effects of interleukin-12. Infect Immun 65: 1307-1312.
23. Koguchi Y, Kawakami K (2002) Cryptococcal infection and Th1-Th2 cytokine balance. Int Rev Immunol 21: 423-438.
24. Blackstock R, Buchanan KL, Adekunle M, Adesina, Murphy JW (1999) Differential Regulation of Immune Responses by Highly and Weakly Virulent Cryptococcus neoformans Isolates. Infect Immun 67: 3601-3609.
25. Muller U, Stenzel W, Kohler G, Werner C, Polte T, et al. (2007) IL-13 Induces Disease-Promoting Type 2 Cytokines, Alternatively Activated Macrophages and Allergic Inflammation during Pulmonary Infection of Mice with Cryptococcus neoformans. J Immunol 179: 5367-5377.
26. Murphy JW, Schafer F, Casadevall A, Adesina A (1998) Antigen-induced protective and nonprotective cell-mediated immune components against Cryptococcus neoformans. Infect Immun 66: 2632-2639.
27. Yauch LE, Lam JS, Levitz SM (2006) Direct Inhibition of T-Cell Responses by the Cryptococcus Capsular Polysaccharide Glucuronoxylomannan. PLoS Pathogens 2: e120.
28. Levitz SM, Nong S, Mansour MK, Huang C, Specht CA (2001) Molecular characterization of a mannoprotein with homology to chitin deacetylases that stimulates T cell responses to Cryptococcus neoformans. Proc Natl Acad Sci U S A 98: 10422-10427.
29. Huang C, Nong SH, Mansour MK, Specht CA, Levitz SM (2002) Purification and characterization of a second immunoreactive mannoprotein from Cryptococcus neoformans that stimulates T-cell responses. Infect Immun 70: 5485-5493.
30. Mandel MA, Grace GG, Orsborn KI, Schafer F, Murphy JW, et al. (2000) The Cryptococcus neoformans gene DHA1 encodes an antigen that elicits a delayed-type hypersensitivity reaction in immune mice. Infect Immun 68: 6196-6201.
31. Biondo C, Beninati C, Delfino D, Oggioni M, Mancuso G, et al. (2002) Identification and cloning of a cryptococcal deacetylase that produces protective immune responses. Infect Immun 70: 2383-2391.
32. Dromer F, Charreire J, Contrepois A, Carbon C, Yeni P (1987) Protection of mice against experimental cryptococcosis by anti-Cryptococcus neoformans monoclonal antibody. Infect Immun 55: 749-752.
33. Mukherjee J, Pirofski LA, Scharff MD, Casadevall A (1993) Antibody-mediated protection in mice with lethal intracerebral Cryptococcus neoformans infection. Proc Natl Acad Sci U S A 90: 3636-3640.
34. Graybill JR, Bocanegra R, Lambros C, Luther MF (1997) Granulocyte colony stimulating factor therapy of experimental cryptococcal meningitis. J Med Vet Mycol 35: 243-247.
35. Clemons KV, Brummer E, Stevens DA (1994) Cytokine treatment of central nervous system infection: efficacy of interleukin-12 alone and synergy with conventional antifungal therapy in experimental cryptococcosis. Antimicrob Agents Chemother 38: 460-464.
36. Joly V, Saint-Julien L, Carbon C, Yeni P (1994) In vivo activity of interferon-gamma in combination with amphotericin B in the treatment of experimental cryptococcosis. J Infect Dis 170: 1331-1334.
37. Kawakami K, Qureshi MH, Zhang T, Okamura H, Kurimoto M, et al. (1997) IL-18 protects mice against pulmonary and disseminated infection with Cryptococcus neoformans by inducing IFN-gamma production. J Immunol 159: 5528-5534.
38. Lutz JE, Clemons KV, Stevens DA (2000) Enhancement of antifungal chemotherapy by interferon-gamma in experimental systemic cryptococcosis. J Antimicrob Chemother 46: 437-442.
39. Pappas PG, Bustamante B, Ticona E, Hamill RJ, Johnson PC, et al. (2004) Recombinant interferon- gamma 1b as adjunctive therapy for AIDS-related acute cryptococcal meningitis. J Infect Dis 189: 2185-2191.
40. Wormley FL Jr, Perfect JR, Steele C, Cox GM (2007) Protection Against Cryptococcosis using a Murine Interferon-gamma Producing Cryptococcus neoformans Strain. Infect Immun 75: 1453-1462.
41. Young M, Macias S, Thomas D, Wormley FL Jr (2009) A proteomic-based approach for the identification of immunodominant Cryptococcus neoformans proteins. Proteomics 9: 2578-2588.
42. Chen GH, McNamara DA, Hernandez Y, Huffnagle GB, Toews GB, et al. (2008) Inheritance of Immune Polarization Patterns Is Linked to Resistance versus Susceptibility to Cryptococcus neoformans in a Mouse Model. Infect Immun 76: 2379-2391.
43. Osterholzer JJ, Curtis JL, Polak T, Ames T, Chen G-H, et al. (2008) CCR2 Mediates Conventional Dendritic Cell Recruitment and the Formation of Bronchovascular Mononuclear Cell Infiltrates in the Lungs of Mice Infected with Cryptococcus neoformans. J Immunol 181: 610-620.
44. Arora S, Hernandez Y, Erb-Downward JR, McDonald RA, Toews GB, et al. (2005) Role of IFN-gamma in regulating T2 immunity and the development of alternatively activated macrophages during allergic bronchopulmonary mycosis. J Immunol 174: 6346-6356.
45. Chen GH, Olszewski MA, McDonald RA, Wells JC, Paine R 3rd, et al. (2007) Role of granulocyte macrophage colony-stimulating factor in host defense against pulmonary Cryptococcus neoformans infection during murine allergic bronchopulmonary mycosis. Am J Pathol 170: 1028-1040.
46. Daley JM, Thomay AA, Connolly MD, Reichner JS, Albina JE (2008) Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice. J Leukoc Biol 83: 64-70.
47. Dalod M, Hamilton T, Salomon R, Salazar-Mather TP, Henry SC, et al. (2003) Dendritic cell responses to early murine cytomegalovirus infection: subset functional specialization and differential regulation by interferon alpha/beta. J Exp Med 197: 885-898.
48. Nakano H, Yanagita M, Gunn MD (2001) CD11c(+)B220(+)Gr-1(+) cells in mouse lymph nodes and spleen display characteristics of plasmacytoid dendritic cells. J Exp Med 194: 1171-1178.
49. Mordue DG, Sibley LD (2003) A novel population of Gr-1+-activated macrophages induced during acute toxoplasmosis. J Leukoc Biol 74: 1015-1025.
50. Huffnagle GB, Lipscomb MF (1998) Cells and cytokines in pulmonary cryptococcosis. Research in Immunology 149: 387-396.
51. Casadevall A (1995) Antibody immunity and invasive fungal infections. Infect Immun 63: 4211-4218.
52. Casadevall A (1998) Antibody-mediated protection against intracellular pathogens. Trends Microbiol 6: 102-107.
53. Davis JM, Ramakrishnan L (2009) The Role of the Granuloma in Expansion and Dissemination of Early Tuberculous Infection. Cell 136: 37-49.
54. Luberto C, Martinez-Marino B, Taraskiewicz D, Bolanos B, Chitano P, et al. (2003) Identification of App1 as a regulator of phagocytosis and virulence of Cryptococcus neoformans. J Clin Invest 112: 1080-1094.
55. Santangelo R, Zoellner H, Sorrell T, Wilson C, Donald C, et al. (2004) Role of Extracellular Phospholipases and Mononuclear Phagocytes in Dissemination of Cryptococcosis in a Murine Model. Infect Immun 72: 2229-2239.
56. Voelz K, Lammas DA, May RC (2009) Cytokine signaling regulates the outcome of intracellular macrophage parasitism by Cryptococcus neoformans. Infect Immun.
57. Casadevall A, Pirofski L (2005) Insights into Mechanisms of Antibody-Mediated Immunity from Studies with Cryptococcus neoformans. Current Molecular Medicine 5: 421-433.
58. Mednick AJ, Feldmesser M, Rivera J, Casadevall A (2003) Neutropenia alters lung cytokine production in mice and reduces their susceptibility to pulmonary cryptococcosis. Eur J Immunol 33: 1744-1753.
59. Herring AC, Falkowski NR, Chen GH, McDonald RA, Toews GB, et al. (2005) Transient neutralization of tumor necrosis factor alpha can produce a chronic fungal infection in an immunocompetent host: Potential role of immature dendritic cells. Infection and Immunity 73: 39-49.
60. Allendoerfer R, Deepe GS Jr (1998) Infection with Histoplasma capsulatum: Host-fungus interface. Rev Iberoam Micol 15: 256-260.
61. Allendoerfer R, Deepe GS Jr (1998) Blockade of endogenous TNF-alpha exacerbates primary and secondary pulmonary histoplasmosis by differential mechanisms. J Immunol 160: 6072-6082.
62. Zhou P, Miller G, Seder RA (1998) Factors involved in regulating primary and secondary immunity to infection with Histoplasma capsulatum: TNF-alpha plays a critical role in maintaining secondary immunity in the absence of IFN-gamma. J Immunol 160: 1359-1368.
63. Deepe GS Jr, Gibbons RS (2006) T cells require tumor necrosis factor-alpha to provide protective immunity in mice infected with Histoplasma capsulatum. J Infect Dis 193: 322-330.
64. Cain JA, Deepe GS Jr (1998) Evolution of the primary immune response to Histoplasma capsulatum in murine lung. Infect Immun 66: 1473-1481.
65. Wuthrich M, Filutowicz HI, Warner T, Klein BS (2002) Requisite elements in vaccine immunity to Blastomyces dermatitidis: plasticity uncovers vaccine potential in immune-deficient hosts. J Immunol 169: 6969-6976.
66. Cox GM, McDade HC, Chen SC, Tucker SC, Gottfredsson M, et al. (2001) Extracellular phospholipase activity is a virulence factor for Cryptococcus neoformans. Mol Microbiol 39: 166-175.
67. Cox GM, Mukherjee J, Cole GT, Casadevall A, Perfect JR (2000) Urease as a virulence factor in experimental cryptococcosis. Infect Immun 68: 443-448.